DEC 04, 2017 3:16 PM PST

Kill Cancer Gently, Kill Cancer More Completely

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

It’s tragically ironic that in cancer medicine, sometimes the process of killing off cancer cells can spur new tumors to form. The phenomenon is known as the “tumor growth paradox” and it illustrates the complexities behind tumor biology and highlights the need for more refined interventions when dealing with cancer.

To avoid inadvertently giving cancer the edge during treatment, researchers from the Institute of Systems Biology in Seattle, WA, say a more “gentle” approach may be key.

"Our studies, along with others, show that traditional cancer therapy may be a 'double-edged sword,' wherein the very treatment used to cure cancer is also helping it survive and grow,” explained the authors of the new study.

Chemotherapies and other treatments that hope to obliterate cancer cells can leave behind a collection of dead or dying cells. This mass of “tumor cell debris” is capable of triggering a malicious chain of events, including the promotion of new cancer cells.

As it turns out, the surface of these cells have a lipid called phosphatidylserine, which “generates a 'cytokine storm' of pro-inflammatory pro-tumorigenic cytokines." This inflammatory process can act like a breeze that reignites the few smoldering cancer cells that survived the initial treatment. And with time, another cancer wildfire begins anew.

The authors describe this as “the 'perfect storm' for cancer progression.” They also conclude this is how conventional chemotherapy “may contribute to tumor relapse.”

Instead of focusing on harsher and more poisonous cancer drugs, the research team approached the problem from a different angle: they wanted to reduce the wind that could reignite cancer’s progression.

To do so, the team used resolvins, “a natural product of tissue that serves as a stop signal to end the inflammatory process.” In essence, this compound acts like water to stop the smoldering process in cancer cells.

Indeed, treatment with resolvins quelled the inflammatory process and stopped cancer cells from progressing. Resolvins also improved the efficacy of other anticancer drugs when treated in combination.

“In brief, we learn that when it comes to cancer therapy: 'Thou shall not kill — or kill gently and remove dead bodies immediately,'" said Sui Huang, the study’s senior author, from the Institute of Systems Biology in Seattle, WA.

"The findings underscore the old idea that killing cancer cells with more and more effective drugs may backfire," added Huang. "The tumor tissue is a reactive system that turns cell-killing therapy into double-edge[d] swords: the more you kill the more you may stimulate the surviving tumor cells.”

“Overcoming the dilemma of debris-induced tumor progression is paramount if we are to prevent tumor recurrence of treatment-resistant tumors — the major reason for [the] failure of cancer therapy,” the authors said.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 08, 2020
Cancer
Oral cancer pain levels indicate metastasis
OCT 08, 2020
Oral cancer pain levels indicate metastasis
A new study from NYU College of Dentistry researchers provides insight as to why patients with metastatic oral cancer ex ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
OCT 18, 2020
Microbiology
Mouth Microbes Play a Role in Oral Cancer Development
OCT 18, 2020
Mouth Microbes Play a Role in Oral Cancer Development
Oral hygiene is not only important for keeping teeth and gums healthy; it can also affect a person's health in general.
NOV 15, 2020
Genetics & Genomics
Novel Cancer-Driving Genes are Discovered
NOV 15, 2020
Novel Cancer-Driving Genes are Discovered
Cells have to be able to divide so new ones can replenish cells that get worn out, dysfunctional, or that accumulate dam ...
NOV 20, 2020
Cancer
How does tissue geometry influence cancer cellular migration?
NOV 20, 2020
How does tissue geometry influence cancer cellular migration?
A team of researchers led by UC Santa Barbara's Distinguished Professor Denise Montell has recently published new fi ...
NOV 23, 2020
Cancer
Women show higher survival rates than men post lung cancer surgery
NOV 23, 2020
Women show higher survival rates than men post lung cancer surgery
New research published in the journal Chest shows that women fare better than men following lung cancer surgery. Th ...
Loading Comments...